Prevalence of overactive bladder in C hina, T aiwan and S outh K orea: R esults from a cross‐sectional, population‐based study YC Chuang, SP Liu, KS Lee, L Liao, J Wang, TK Yoo, R Chu, ... LUTS: Lower Urinary Tract Symptoms 11 (1), 48-55, 2019 | 98 | 2019 |
Prevalence of lower urinary tract symptoms in China, Taiwan, and South Korea: results from a cross-sectional, population-based study C Chapple, D Castro-Diaz, YC Chuang, KS Lee, L Liao, SP Liu, J Wang, ... Advances in Therapy 34, 1953-1965, 2017 | 98 | 2017 |
Mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: a randomized, placebo-controlled study (MATCH) H Kakizaki, KS Lee, O Yamamoto, JJ Jong, D Katou, B Sumarsono, S Uno, ... European urology focus 6 (4), 729-737, 2020 | 62 | 2020 |
The prevalence of lower urinary tract symptoms in population aged 40 years or over, in South Korea TK Yoo, KS Lee, B Sumarsono, ST Kim, HJ Kim, HC Lee, SH Kim Investigative and clinical urology 59 (3), 166, 2018 | 44 | 2018 |
Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population … KS Lee, TK Yoo, L Liao, J Wang, YC Chuang, SP Liu, R Chu, ... BMC urology 17, 1-10, 2017 | 38 | 2017 |
Epidemiology of lower urinary tract symptoms in a cross-sectional, population-based study: The status in China JY Wang, L Liao, M Liu, B Sumarsono, M Cong Medicine 97 (34), e11554, 2018 | 34 | 2018 |
The prevalence and bother of lower urinary tract symptoms in men and women aged 40 years or over in Taiwan SP Liu, YC Chuang, B Sumarsono, HC Chang Journal of the Formosan Medical Association 118 (1), 170-178, 2019 | 33 | 2019 |
The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study PM Chow, SP Liu, YC Chuang, KS Lee, TK Yoo, L Liao, J Wang, M Liu, ... World Journal of Urology 36, 1853-1862, 2018 | 27 | 2018 |
Prevalence, severity, and associated factors in women in East Asia with moderate-to-severe vasomotor symptoms associated with menopause Q Yu, HD Chae, SM Hsiao, J Xie, M Blogg, B Sumarsono, S Kim Menopause 29 (5), 553-563, 2022 | 22 | 2022 |
The prevalence of urinary incontinence in men and women aged 40 years or over in China, Taiwan and South Korea: A cross‐sectional, prevalence‐based study B Sumarsono, JJ Jong, JY Wang, L Liao, KS Lee, TK Yoo, SP Liu, ... LUTS: Lower Urinary Tract Symptoms 12 (3), 223-234, 2020 | 17 | 2020 |
Effect of lower urinary tract symptoms on the quality of life and sexual function of males in China, Taiwan, and South Korea: Subgroup analysis of a cross‐sectional, population … L Liao, YC Chuang, SP Liu, KS Lee, TK Yoo, R Chu, B Sumarsono, ... LUTS: Lower Urinary Tract Symptoms 11 (2), O78-O84, 2019 | 17 | 2019 |
Utilization of cryopreserved sperm cells based on the indication for storage TK Yoo, KS Lee, B Sumarsono, ST Kim, HJ Kim, HC Lee, SH Kim, ... Investigative and Clinical Urology 59 (3), 177-181, 2018 | 11 | 2018 |
Cardiovascular safety of mirabegron add‐on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the … T Katoh, H Kakizaki, KS Lee, K Ishida, D Katou, O Yamamoto, JJ Jong, ... LUTS: Lower Urinary Tract Symptoms 13 (1), 98-107, 2021 | 3 | 2021 |
EFFICACY AND SAFETY OF ADD-ON MIRABEGRON VS. PLACEBO TO TAMSULOSIN IN MEN WITH OVERACTIVE BLADDER SYMPTOMS (MATCH STUDY): LBA13 H Kakizaki, KS Lee, O Yamamoto, JJ Jong, D Katou, B Sumarsono, S Uno, ... Journal of Urology 199 (4), e988, 2018 | 3 | 2018 |
A treatment prediction strategy for overactive bladder using a machine learning algorithm that utilized data from the FAITH study F Hadi, B Sumarsono, KS Lee, SJ Oh, ST Cho, YC Hsu, P Rasner, ... Neurourology and Urodynamics 42 (6), 1227-1237, 2023 | 2 | 2023 |
Mirabegron add-on therapy to tamsulosin in men with overactive bladder: post hoc analyses of efficacy from the MATCH study H Kakizaki, KS Lee, D Katou, O Yamamoto, B Sumarsono, S Uno, ... Advances in Therapy 38, 739-757, 2021 | 2 | 2021 |
Safety and efficacy of an α1‐blocker plus mirabegron compared with an α1‐blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to … S Herschorn, T Tarcan, YH Jiang, E Chung, F Abdul Hadi, A Steup, ... Neurourology and Urodynamics, 2024 | 1 | 2024 |
300 A TREATMENT PREDICTION STRATEGY FOR OVERACTIVE BLADDER USING A MACHINE LEARNING ALGORITHM THAT UTILISED DATA FROM THE FAITH STUDY FA Hadi, B Sumarsono, Y Hsu, S Cho, K Lee, S Oh, P Rasner Continence 2, 100366, 2022 | 1 | 2022 |
Safety of tacrolimus in autoimmune disease: results from post-marketing surveillance in south korea WH Yoo, SI Lee, TH Kim, JJ Sung, SM Kim, F Hua, B Sumarsono, SH Park Journal of rheumatic diseases 28 (4), 202, 2021 | 1 | 2021 |
Efficacy and safety of add-on mirabegron vs placebo to tamsulosin in men with overactive bladder symptoms (match study) KS Lee, H Kakizaki, O Yamamoto, JJ Jong, D Katou, B Sumarsono, S Uno, ... INTERNATIONAL JOURNAL OF UROLOGY 26, 65-65, 2019 | 1 | 2019 |